Inhibiting -cell malfunction by antioxidation is a novel and interesting treatment approach for T2DM, as Doaa A59 has shown through animal research that melatonin can boost -cell regeneration and safeguard the insulin-producing ability of -cells. Here, INS is linked to type 2 diabetes mellitus.